Delhi Police Bust Cancer Drug Racket
Analysis based on 11 articles · First reported Aug 20, 2026 · Last updated Aug 21, 2026
The bust highlights vulnerabilities in the pharmaceutical supply chain, potentially affecting public trust in cancer drug authenticity and prompting stricter regulatory oversight. It may lead to increased scrutiny of hospital drug handling and distribution, impacting pharmaceutical companies and healthcare providers.
India — Delhi Police's Crime Branch busted an interstate syndicate involved in the illegal procurement, diversion, storage, and sale of counterfeit and illegally obtained high-value anti-cancer medicines. Seventeen people were arrested, and medicines worth around Rs 9 crore, along with Rs 50 lakh in cash, were recovered. The syndicate operated across Delhi-NCR, Mumbai, Hyderabad, Haryana, Uttar Pradesh, and other locations. The medicines were sourced through three channels: counterfeit drugs from unauthorized sources, medicines diverted from hospitals meant for cancer patients, and government-supplied medicines diverted from institutions and warehouses. The accused repackaged the medicines, removing batch numbers and MRP details using chemicals like acetone. Raids were conducted on July 11 in Delhi and Navi Mumbai, and an FIR was registered on July 12. The investigation is ongoing to trace the full network and financial trail.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard